Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Theralase Technologies Inc. V.TLT

Alternate Symbol(s):  TLTFF

Theralase Technologies Inc. is a Canada-based clinical-stage pharmaceutical company. The Company is engaged in the research and development of light activated compounds and their associated drug formulations. The Company operates through two divisions: Anti-Cancer Therapy (ACT) and Cool Laser Therapy (CLT). The Anti-Cancer Therapy division develops patented, and patent pending drugs, called Photo Dynamic Compounds (PDCs) and activates them with patent pending laser technology to destroy specifically targeted cancers, bacteria and viruses. The CLT division is responsible for the Company’s medical laser business. The Cool Laser Therapy division designs, develops, manufactures and markets super-pulsed laser technology indicated for the healing of chronic knee pain. The technology has been used off-label for healing numerous nerve, muscle and joint conditions. The Company develops products both internally and using the assistance of specialist external resources.


TSXV:TLT - Post by User

Bullboard Posts
Comment by james700on Jan 13, 2015 6:03pm
148 Views
Post# 23315721

RE:great move today. we should really work

RE:great move today. we should really work
$0.60 has no relevance to anything. It is simply half way down from the high. If you want relevance then we should talk about earnings per share or market cap, then you can come up with a share price comparable to other companies in the same field. If this company has enough of funds to prove their cancer treatment in a human trial then there is a possibility that a market cap of 1-5 Billion is a viable target. If however the company proves to run out of money, well then this fabulous technology will be bought at record low prices by private capital interests and leave share holders and creditors holding the bag. I invested a large sum of money in BXI, only to have them file for bankruptcy and sell their intellectual property to a German venture capitalist. BXI technology is now being commercialised by TEUTEXX Proteins free from all the investors and creditors...
Bullboard Posts